Anaphylaxis to topical bacitracin ointment.
Greenberg
Karen
K
Emergency Medicine Department, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Kennedy Health System-Stratford Division, Stratford, NJ 08084, USA. kjgreenb@yahoo.com
Espinosa
James
J
Scali
Victor
V
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001414:Bacitracin / Q000009:adverse effects*; D004837:Epinephrine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014662:Vasoconstrictor Agents; D001414:Bacitracin; D004837:Epinephrine